CSS
INO icon

Cubist Systematic Strategies’s Inovio Pharmaceuticals INO Stock Holding History

Cubist Systematic Strategies’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-171,561
Closed -$349K – 3254
2025
Q2 		$349K Buy
+171,561
New +$329K ﹤0.01% 2402
2024
Q1 		– Sell
-1,000
Closed -$6.12K – 3976
2023
Q4 		$6.12K Buy
1,000
+497
+99% +$2.45K ﹤0.01% 3413
2023
Q3 		$2.35K Buy
+503
New +$2.78K ﹤0.01% 3200
2023
Q2 		– Sell
-9,929
Closed -$97.7K – 3894
2023
Q1 		$97.7K Sell
9,929
-12,555
-56% -$214K ﹤0.01% 3448
2022
Q4 		$421K Sell
22,484
-13,179
-37% -$299K ﹤0.01% 3137
2022
Q3 		$738K Buy
+35,663
New +$913K ﹤0.01% 2875
2022
Q1 		– Sell
-5,307
Closed -$318K – 3654
2021
Q4 		$318K Buy
5,307
+5,099
+2,451% +$408K ﹤0.01% 2754
2021
Q3 		$18K Buy
+208
New +$20.9K ﹤0.01% 2891
2021
Q2 		– Sell
-2,443
Closed -$272K – 2991
2021
Q1 		$272K Buy
2,443
+1,765
+260% +$232K ﹤0.01% 2315
2020
Q4 		$72K Sell
678
-2,957
-81% -$394K ﹤0.01% 2435
2020
Q3 		$506K Buy
+3,635
New +$758K 0.01% 1738
2020
Q1 		– Sell
-1,042
Closed -$41K – 2287
2019
Q4 		$41K Buy
+1,042
New +$31.4K ﹤0.01% 2291
2019
Q3 		– Sell
-2,734
Closed -$96K – 2325
2019
Q2 		$96K Buy
2,734
+1,596
+140% +$63.4K ﹤0.01% 2238
2019
Q1 		$51K Sell
1,138
-440
-28% -$22.2K ﹤0.01% 2102
2018
Q4 		$76K Buy
+1,578
New +$95.9K ﹤0.01% 1805
2018
Q2 		– Sell
-1,695
Closed -$96K – 1906
2018
Q1 		$96K Buy
+1,695
New +$91.7K 0.01% 1598
2015
Q4 		– Sell
-3,338
Closed -$232K – 1843
2015
Q3 		$232K Buy
+3,338
New +$291K 0.01% 1388

Other funds holding INO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cubist Systematic Strategies's INO Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Inovio Pharmaceuticals (INO) in Q3 2025, closing a stake of 171,561 shares — an estimated $349K sold.

Cubist Systematic Strategies first reported a position in INO in Q3 2015 and held it in 17 quarters. The position peaked at $738K in Q3 2022. 99 funds tracked by Wall St. Rank hold INO as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Inovio Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 171,561 Inovio Pharmaceuticals shares in Q3 2025, an estimated $349K.
  • Cubist Systematic Strategies first reported a position in Inovio Pharmaceuticals in Q3 2015 and held it in 17 quarters.
  • Cubist Systematic Strategies's Inovio Pharmaceuticals position peaked at $738K in Q3 2022.
  • 99 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.